BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36248712)

  • 1. PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.
    Huang Y; Zhou J; Zhou K; Huang B; Xue J; Zhang X; Liu B; Zhang Z; Zhou L; Cai T; Zhang Y; Hu Z; Wang L; Liu X
    PeerJ; 2022; 10():e14193. PubMed ID: 36248712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
    Zhou K; Zhou J; Zhou L; Xue J; Liu B; Zhang Z; Zhang X; Cai T; Shao S; Huang B; Zhang Y; Hu Z; Wang L; Liu X
    PLoS One; 2024; 19(5):e0302100. PubMed ID: 38718066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
    Liu X; Xue J; Li T; Wu Q; Sheng H; Yang X; Lin B; Zhou X; Qin Y; Huang Z; Zhou L; Wang L; Hu Z; Huang B
    PLoS One; 2024; 19(2):e0298269. PubMed ID: 38386672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy.
    Liu X; Xue J; Guo X; Ding Y; Zhang Y; Zhang X; Huang Y; Huang B; Hu Z; Lu G; Wang L
    J Healthc Eng; 2021; 2021():1521013. PubMed ID: 34512932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 receptor.
    Li T; Wu Q; Yang X; Zhang Y; Zhou X; Sheng H; Wang Y; Zhang Q; Liu X; Qin Y; Huang B; Wang L; He Q; Hu Z
    Clin Biochem; 2021 Oct; 96():49-55. PubMed ID: 34252448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
    Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
    Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy.
    Huang B; Zhang Y; Wang L; Xu W; Zhang J; Zhang Q; Sheng H; Hu Z
    Kidney Blood Press Res; 2019; 44(4):848-857. PubMed ID: 31242492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
    Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to immunosuppressive therapy in PLA
    Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
    BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis.
    Zhang J; Fan Z; Wang P; Zhang AH
    Kidney Blood Press Res; 2023; 48(1):102-113. PubMed ID: 36720217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy.
    Zhang Y; Liu Y; Liang L; Liu L; Tang X; Tang L; Chen P; Chen J; Wang Z; Cao W; Chen Q; Zhao N; Xu D
    Kidney Blood Press Res; 2020; 45(5):713-726. PubMed ID: 32894840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and clinical significance of glomerular M-type phospholipase A
    Liu H; Luo W; Gong S; Ding X
    Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Significance of IgG4 Level in Predicting the Activity and Outcome of Phospholipase A2 Receptor-associated Membranous Nephropathy].
    DU YY; Jiang X; Wang WR; Tang XL; Sun Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):579-584. PubMed ID: 36065689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy.
    Zhang Y; Huang Y; Huang B; Chen X; Zhou B; Zou P; Wang L; Liu X; Sheng H; Xie M
    Biomed Res Int; 2022; 2022():9127520. PubMed ID: 35782060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.
    Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM
    Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
    Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J
    J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach.
    Wang S; Deng Z; Wang Y; Bao W; Zhou S; Cui Z; Zheng D
    BMC Nephrol; 2023 May; 24(1):146. PubMed ID: 37237260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: The optimal cut-off value for Chinese patients.
    Liu Y; Li X; Ma C; Wang P; Liu J; Su H; Zhuo H; Kong X; Xu D; Xu D
    Clin Chim Acta; 2018 Jan; 476():9-14. PubMed ID: 29126817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Predictive Value of Phospholipase A2 Receptor Gene Polymorphism Combined with Subclass of Immunoglobulin G in Renal Tissues for Membranous Nephropathy.
    Ji C; Xu Q; Bian X
    Altern Ther Health Med; 2023 Oct; 29(7):418-423. PubMed ID: 37535917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.